Compare · MD vs PACS
MD vs PACS
Side-by-side comparison of Pediatrix Medical Group Inc. (MD) and PACS Group Inc. (PACS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MD and PACS operate in Hospital/Nursing Management (Health Care), so they compete in similar markets.
- PACS is the larger of the two at $5.78B, about 3.2x MD ($1.79B).
- Over the past year, MD is up 57.3% and PACS is up 258.8% - PACS leads by 201.6 points.
- MD has been more active in the news (17 items in the past 4 weeks vs 5 for PACS).
- MD has more recent analyst coverage (9 ratings vs 6 for PACS).
- Company
- Pediatrix Medical Group Inc.
- PACS Group Inc.
- Price
- $21.86+0.85%
- $36.53-1.06%
- Market cap
- $1.79B
- $5.78B
- 1M return
- -2.37%
- +12.33%
- 1Y return
- +57.27%
- +258.84%
- Industry
- Hospital/Nursing Management
- Hospital/Nursing Management
- Exchange
- NYSE
- NYSE
- IPO
- 2024
- News (4w)
- 17
- 5
- Recent ratings
- 9
- 6
Pediatrix Medical Group Inc.
MEDNAX, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of March 16, 2021, it operated a network of approximately 2,300 physicians. The company was founded in 1979 and is based in Sunrise, Florida.
Latest MD
- EVP, CFO and Treasurer Rossi Kasandra H was granted 31,800 shares and covered exercise/tax liability with 3,701 shares, increasing direct ownership by 38% to 101,399 units (SEC Form 4)
- Chief Executive Officer Ordan Mark S was granted 224,372 shares, covered exercise/tax liability with 19,119 shares and returned 97,174 shares to the company, increasing direct ownership by 36% to 410,884 units (SEC Form 4)
- EVP, Chief Invest & Strategy Neeb Don Gregory covered exercise/tax liability with 8,003 shares and was granted 63,888 shares, increasing direct ownership by 69% to 137,231 units (SEC Form 4)
- EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 11,944 shares, decreasing direct ownership by 11% to 96,466 units (SEC Form 4)
- Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology
- SEC Form S-8 filed by Pediatrix Medical Group Inc.
- Director Weis Shirley A sold $855,665 worth of shares (36,028 units at $23.75) (SEC Form 4)
- Director Mceachin Thomas gifted 11,427 shares and received a gift of 11,427 shares, decreasing direct ownership by 61% to 7,196 units (SEC Form 4)
- EVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 40,826 shares, decreasing direct ownership by 27% to 108,410 units (SEC Form 4)
- Director Rucker Michael A. was granted 7,196 shares, increasing direct ownership by 12% to 66,297 units (SEC Form 4)
Latest PACS
- Chief Legal Officer & Sec. Mitchell John Todd sold $3,023,706 worth of shares (80,152 units at $37.72) as part of a pre-agreed trading plan, decreasing direct ownership by 9% to 803,566 units (SEC Form 4)
- SEC Form 144 filed by PACS Group Inc.
- PACS Group, Inc. Reports First Quarter 2026 Results
- PACS Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- SEC Form 10-Q filed by PACS Group Inc.
- PACS Group Intends to Release First Quarter 2026 Earnings on Monday, May 11, 2026, and Host a Call to Discuss Financial Results on Tuesday, May 12, 2026
- PACS Group Announces Acquisition in Alaska; New Construction of a Skilled Nursing Community
- SEC Form DEFA14A filed by PACS Group Inc.
- SEC Form DEF 14A filed by PACS Group Inc.
- SEC Form 3 filed by new insider Hendrickson Carey P